在人类骨质疏松症的管理中小干扰RNAs
Giuseppe Gargano1,2,3, Giovanni Asparago1,2, Filippo Spiezia3
1Department of Trauma and Orthopaedic Surgery, AOU San Giovanni di Dio e Ruggi D'Aragona, Via San Leonardo 1, 84131 Salerno, Italy.
British medical bulletin
|September 7, 2023
概括
通过向代谢过程,小干扰RNAs (siRNAs) 显示出对骨质疏松症治疗的希望. 然而,体外试验结果可能无法准确预测体外疗效,这突出了一个关键的研究挑战.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨质疏松症的特点是骨质量减少和骨脆弱性增加.
- 小干扰RNAs (siRNAs) 被用于治疗应用,作为分子标,以及测试新疗法.
研究的目的:
- 确定siRNAs在骨质疏松症治疗中的作用.
- 探索siRNAs在了解和治疗骨质疏松症方面的潜力.
主要方法:
- 在多个数据库中进行了系统的文献搜索,直到2023年5月.
- 确定并分析了14项相关研究,调查骨质疏松症中的siRNAs.
主要成果:
- siRNAs显示出研究骨质疏松代谢过程和确定治疗点的潜力.
- 由siRNAs引起的基因失调可以影响参与代谢过程的生长因子.
结论:
- siRNAs可能成为骨质疏松症研究和药物开发的宝贵工具.
- 基于体外数据预测体内siRNA药物反应仍然是一个重大挑战.
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Small interfering RNAs (siRNA)
3.6K
3.6K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Bone Remodeling
38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K


